Metformin can mediate direct inhibitory effects on glycolysis of cancer cells by inhibiting the rate limiting enzyme HK2 (133) but also has direct effects on the mitochondrial electron transport chain by abrogating the function of complex I (134). Here, HK2 is linked to cancer.